Seeking Alpha

CardioNet (BEAT), just renamed BioTelemetry, soared by 38% on a day a couple weeks ago, taking this tiny company to a market capitalization of approximately $192 million by the close of trading. The huge gain came on extraordinary volume of 8.99 million shares traded, versus the 3-month average of 730K. Obviously, there was a catalyst, and it was the best possible of all drivers that moved the shares. CardioNet reported its second quarter earnings after the close of trading the day before, and I think it's safe to say the news was well received. We take a closer look at the results and the company herein. After seven years of following small-cap stocks as a senior analyst...

Only subscribers can access this article, which is part of the PRO research library covering 3,808 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: